Literature DB >> 33500180

Laparoscopic approach for T4 colon cancer can be associated with poor prognosis in right-sided T4b tumours.

Kiho You1, Hyoung-Chul Park2, Sung Chan Park1, Dae Kyung Sohn1, Jae Hwan Oh1, Dong-Won Lee1, Sung-Sil Park1, Sung-Bum Kang3, Seung Chul Heo4, Min Jung Kim5, Kyu Joo Park6.   

Abstract

INTRODUCTION: Although recent studies have demonstrated the safety of laparoscopic surgery in T4 colon cancer, some patients could have poor prognosis. In this study, we aimed to analyse the risk factors affecting oncologic outcome of laparoscopic surgery.
MATERIALS AND METHODS: Among the 1033 T4 colon cancer patients collected from a multicentre database (2004-2017), 584 patients (458 T4a and 126 T4b) underwent laparoscopic approach for radical surgery. Risk factors associated with 3-year disease-free survival (DFS) and overall survival (OS) were evaluated through multivariate analysis. In addition, subgroups were classified using a combination of risk factors, and the survival rate was evaluated.
RESULTS: During this period, 188 (32.2%) had recurrence, and 151 (25.9%) died. In the multivariate analysis for oncologic outcome, elevated carcinoembryonic antigen level (hazard ratio [HR] 1.37) and absence of adjuvant chemotherapy (HR 1.60) were associated with poor DFS. T4b (HR 1.56, 1.46), right-sided location (HR 1.52, 1.42), and open conversion (HR 2.70, 2.12) were independently associated with both poor DFS and OS. When four subgroups were analysed through the combination of tumour location and T stage, the DFS and OS rates were significantly lower in patients with right-sided T4b cancer than in other groups (log-rank p < 0.001).
CONCLUSION: Right-sided T4b colon cancer for laparoscopic surgery may lead to poor oncologic outcome. This approach could be a caution in suspected cases preoperatively.
Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Laparoscopy; Oncologic outcomes; T4 colon cancer; Tumour location

Year:  2021        PMID: 33500180     DOI: 10.1016/j.ejso.2021.01.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  1 in total

1.  CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule.

Authors:  Yuki Nakagami; Shoichi Hazama; Nobuaki Suzuki; Shin Yoshida; Shinobu Tomochika; Hiroto Matsui; Yoshitaro Shindo; Yukio Tokumitsu; Satoshi Matsukuma; Yusaku Watanabe; Michihisa Iida; Ryouichi Tsunedomi; Shigeru Takeda; Tomonobu Fujita; Yutaka Kawakami; Hiroyuki Ogihara; Yoshihiko Hamamoto; Tatsuya Ioka; Tsuyoshi Tanabe; Tomio Ueno; Hiroaki Nagano
Journal:  BMC Cancer       Date:  2022-10-18       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.